[ad_1]
Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic most cancers. Lancet. 2020;395(10242):2008–20.
Thomas D, Radhakrishnan P. Tumor-stromal crosstalk in pancreatic most cancers and tissue fibrosis. Mol Most cancers. 2019;18(1):14.
Ho WJ, Jaffee EM, Zheng L. The tumour microenvironment in pancreatic most cancers—scientific challenges and alternatives. Nat Rev Clin Oncol. 2020;17(9):527–40.
Lankadasari MB, Mukhopadhyay P, Mohammed S, Harikumar KB. TAMing pancreatic most cancers: fight with a double edged sword. Mol Most cancers. 2019;18(1):48.
Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to remedy. Immunity. 2014;41(1):49–61.
Cassetta L, Pollard JW. Focusing on macrophages: therapeutic approaches in most cancers. Nat Rev Drug Discov. 2018;17(12):887–904.
Pathria P, Louis TL, Varner JA. Focusing on tumor-associated macrophages in most cancers. Traits Immunol. 2019;40(4):310–27.
D’Errico G, Alonso-Nocelo M, Vallespinos M, Hermann PC, Alcalá S, García CP, Martin-Hijano L, Valle S, Earl J, Cassiano C, Lombardia L, Feliu J, Monti MC, Seufferlein T, García-Bermejo L, Martinelli P, Carrato A, Sainz B Jr. Tumor-associated macrophage-secreted 14-3-3ζ alerts through AXL to advertise pancreatic most cancers chemoresistance. Oncogene. 2019;38(27):5469–85.
Mitchem JB, Brennan DJ, Knolhoff BL, Belt BA, Zhu Y, Sanford DE, Belaygorod L, Carpenter D, Collins L, Piwnica-Worms D, Hewitt S, Udupi GM, Gallagher WM, Wegner C, West BL, Wang-Gillam A, Goedegebuure P, Linehan DC, DeNardo DG. Focusing on tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Most cancers Res. 2013;73(3):1128–41.
Wu C, Tan X, Hu X, Zhou M, Yan J, Ding C. Tumor microenvironment following gemcitabine remedy favors differentiation of immunosuppressive Ly6C(excessive) myeloid cells. J Immunol. 2020;204(1):212–23.
Bulle A, Dekervel J, Deschuttere L, Nittner D, Libbrecht L, Janky R, Plaisance S, Topal B, Coosemans A, Lambrechts D, Van Cutsem E, Verslype C, van Pelt J. Gemcitabine recruits M2-type tumor-associated macrophages into the stroma of pancreatic most cancers. Transl Oncol. 2020;13(3):100743.
Yang Y, Guo J, Huang L. Tackling TAMs for most cancers immunotherapy: it’s nano time. Traits Pharmacol Sci. 2020;41(10):701–14.
Cieslewicz M, Tang J, Yu JL, Cao H, Zavaljevski M, Motoyama Ok, Lieber A, Raines EW, Pun SH. Focused supply of proapoptotic peptides to tumor-associated macrophages improves survival. Proc Natl Acad Sci USA. 2013;110(40):15919–24.
Qian Y, Qiao S, Dai Y, Xu G, Dai B, Lu L, Yu X, Luo Q, Zhang Z. Molecular-targeted immunotherapeutic technique for melanoma through dual-targeting nanoparticles delivering small interfering RNA to tumor-associated macrophages. ACS Nano. 2017;11(9):9536–49.
Van Beijnum JR, Moerkerk PT, Gerbers AJ, De Bruïne AP, Arends JW, Hoogenboom HR, Hufton SE. Goal validation for genomics utilizing peptide-specific phage antibodies: a research of 5 gene merchandise overexpressed in colorectal most cancers. Int J Most cancers. 2002;101(2):118–27.
Valcourt DM, Harris J, Riley RS, Dang M, Wang J, Day ES. Advances in focused nanotherapeutics: from bioconjugation to biomimicry. Nano Res. 2018;11(10):4999–5016.
Gao X, Li S, Ding F, Liu X, Wu Y, Li J, Feng J, Zhu X, Zhang C. A virus-mimicking nucleic acid nanogel reprograms microglia and macrophages for glioblastoma remedy. Adv Mater. 2021;33(9):e2006116.
Zhou J, Kroll AV, Holay M, Fang RH, Zhang L. Biomimetic nanotechnology towards customized vaccines. Adv Mater. 2020;32(13): e1901255.
Hao H, Chen Y, Wu M. Biomimetic nanomedicine towards customized illness theranostics. Nano Res. 2020;14(8):2491–511.
Huang Y, Mei C, Tian Y, Nie T, Liu Z, Chen T. Bioinspired tumor-homing nanosystem for exact most cancers remedy through reprogramming of tumor-associated macrophages. NPG Asia Supplies. 2018;10(10):1002–15.
Xue J, Sharma V, Hsieh MH, Chawla A, Murali R, Pandol SJ, Habtezion A. Alternatively activated macrophages promote pancreatic fibrosis in continual pancreatitis. Nat Commun. 2015;6:7158.
Zhu Y, Herndon JM, Sojka DK, Kim KW, Knolhoff BL, Zuo C, Cullinan DR, Luo J, Bearden AR, Lavine KJ, Yokoyama WM, Hawkins WG, Fields RC, Randolph GJ, DeNardo DG. Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor development. Immunity. 2017;47(2):323-338.e6.
Wang C, Wang J, Zhang X, Yu S, Wen D, Hu Q, Ye Y, Bomba H, Hu X, Liu Z, Dotti G, Gu Z. In situ fashioned reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for mixture remedy. Sci Transl Med. 2018;10(429):eaan3682.
Ibrahimova V, Zhao H, Ibarboure E, Garanger E, Lecommandoux S. Thermosensitive vesicles from chemically encoded lipid-grafted elastin-like polypeptides. Angew Chem Int Ed Engl. 2021;60(27):15036–40.
Chen Q, Huang G, Wu W, Wang J, Hu J, Mao J, Chu PK, Bai H, Tang G. A hybrid eukaryotic-prokaryotic nanoplatform with photothermal modality for enhanced antitumor vaccination. Adv Mater. 2020;32(16): e1908185.
Huang X, Zhang G, Tang T, Liang T. Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine growth. Mol Most cancers. 2021;20(1):44.
Zhang Y, Velez-Delgado A, Mathew E, Li D, Mendez FM, Flannagan Ok, Rhim AD, Simeone DM, Beatty GL, di Magliano MP. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the institution of an immunosuppressive surroundings in pancreatic most cancers. Intestine. 2017;66(1):124–36.
Weizman N, Krelin Y, Shabtay-Orbach A, Amit M, Binenbaum Y, Wong RJ, Gil Z. Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase. Oncogene. 2014;33(29):3812–9.
Matsuki H, Hiroshima Y, Miyake Ok, Murakami T, Homma Y, Matsuyama R, Morioka D, Kurotaki D, Tamura T, Endo I. Discount of gender-associated M2-like tumor-associated macrophages within the tumor microenvironment of sufferers with pancreatic most cancers after neoadjuvant chemoradiotherapy. J Hepatobiliary Pancreat Sci. 2021;28(2):174–82.
Qiu N, Wang G, Wang J, Zhou Q, Guo M, Wang Y, Hu X, Zhou H, Bai R, You M, Zhang Z, Chen C, Liu Y, Shen Y. Tumor-associated macrophage and tumor-cell dually transfecting polyplexes for environment friendly interleukin-12 most cancers gene remedy. Adv Mater. 2021;33(2): e2006189.
Shen S, Li HJ, Chen KG, Wang YC, Yang XZ, Lian ZX, Du JZ, Wang J. Spatial focusing on of tumor-associated macrophages and tumor cells with a pH-sensitive cluster nanocarrier for most cancers chemoimmunotherapy. Nano Lett. 2017;17(6):3822–9.
Ho TTB, Nasti A, Seki A, Komura T, Inui H, Kozaka T, Kitamura Y, Shiba Ok, Yamashita T, Yamashita T, Mizukoshi E, Kawaguchi Ok, Wada T, Honda M, Kaneko S, Sakai Y. Mixture of gemcitabine and anti-PD-1 antibody enhances the anticancer impact of M1 macrophages and the Th1 response in a murine mannequin of pancreatic most cancers liver metastasis. J Immunother Most cancers. 2020;8(2):e001367.
[ad_2]
